Fascinating how Medlab reached it phase2 goal as a success ready...

Fascinating how Medlab reached it phase2 goal as a success ready for phase3, but it lost 50% of share price valu3. Yet BOT failed its acne cream trial turned it into antimicrobial cream trial and is worth double MDC market capital. BOT has no income either and attempting to use the cream for something else after finding out not good for acne... yet Medlab reaches its goal and loses 50% of value aftet waiting 2 years for the phase2 to be proven as successful. Why doesnt this make sense to me?

also BOT went as low as 2cents after poor results but has now x5 and back up to 10c to be a 100mill$ company. MEDLAB still struggling to be a 50mill$ company. Surely penny should drop at some point.

and i cannot believe for many months MDC was exactly same value as MXC... unbelievable. Surely MDC should be worth multiples of current sp especially after succeeding its phase2 for alternative to opioids. And has nothing to do with income as a company with a cream that failed and no income is worth 100mill$.

what am i missing?

as always great presentation by the company and scratches my head in disbelief at the same time.

glta